Characteristics | N | All 672 | PLHIV 440 | PWoH 232 | P-value |
---|---|---|---|---|---|
Age (years), Median (Q1, Q3) | 672 | 42 (34, 50) | 45 (36, 52) | 40 (26, 46.5) |  < 0.001W |
Gender, Female n (%) | 672 | 335 (49.9) | 222 (50.5) | 119 (51.3) | 0.686F |
Education, n (%) | 672 |  |  |  |  < 0.001F |
 None/Primary |  | 139 (20.7) | 105 (23.9) | 34 (14.6) |  |
 Junior/Senior Secondary |  | 236 (35.1) | 163 (37.0) | 73 (31.5) |  |
 Tertiary |  | 297 (44.2) | 172 (39.1) | 125 (53.9) |  |
Occupation, n (%) | 672 |  |  |  |  < 0.001F |
 Civil Service/Governmental |  | 152 (22.6) | 100 (22.7) | 52 (22.4) |  |
 Non-governmental |  | 68 (10.1) | 21 (4.8) | 47 (20.3) |  |
 Self-employed |  | 359 (53.4) | 290 (65.9) | 69 (29.7) |  |
 Student |  | 62 (9.2) | 6 (1.4) | 56 (24.1) |  |
 Unemployed |  | 31 (4.6) | 23 (5.2) | 8 (3.5) |  |
Monthly Income (× 103 ₦), Median (Q1, Q3) | 671 | 30 (10, 50) | 30 (10, 60) | 20 (15, 46) | 0.002W |
Marital Status, n (%) | 672 |  |  |  |  < 0.001F |
 Married |  | 469 (69.8) | 323 (73.4) | 146 (62.9) |  |
 Widowed |  | 32 (4.8) | 30 (6.8) | 2 (0.86) |  |
 Divorced |  | 5 (0.74) | 4 (0.91) | 1 (0.43) |  |
 Separated |  | 47 (7.0) | 36 (8.2) | 11 (4.7) |  |
 Single/Never Married |  | 119 (17.7) | 47 (10.7) | 72 (31.0) |  |
Smoking, n (%) | 672 | Â | Â | Â | 0.249F |
 Current |  | 16 (2.4) | 10 (2.3) | 6 (2.6) |  |
 Past |  | 26 (3.9) | 21 (4.8) | 5 (2.2) |  |
 Never |  | 630 (93.7) | 409 (92.9) | 221 (95.3) |  |
Smoking (Past or Current), n (%) | Â | 42 (6.3) | 31 (7.1) | 11 (4.7) | 0.315F |
Alcohol Use, n (%) | 670 | Â | Â | Â | 0.004F |
 Current |  | 36 (5.4) | 23 (5.2) | 13 (5.6) |  |
 Past |  | 54 (8.1) | 46 (10.5) | 8 (3.5) |  |
 Never |  | 580 (86.6) | 370 (84.3) | 210 (90.9) |  |
Alcohol Use (Past or Current), n (%) | 670 | 90 (13.4) | 69 (15.7) | 21 (9.1) | 0.017F |
Physical Exercise, n (%) | 672 | 73 (10.9) | 42 (9.6) | 31 (13.4) | 0.151F |
ART Duration (years), Median (Q1, Q3) | 439 | Â | 12 (7, 15) | Â | Â |
CD4 cell count/μL, Median (Q1, Q3) | 435 |  | 549 (403, 737) |  |  |
WHO stage, n (%) | 439 | Â | Â | Â | Â |
 I |  |  | 408 (92.9) |  |  |
 II |  |  | 28 (6.4) |  |  |
 III |  |  | 2 (0.46) |  |  |
 IV |  |  | 1 (0.23) |  |  |
ART Regimen, n (%) | 439 | Â | Â | Â | Â |
 TDF + 3TC (or FTC) + EFV |  |  | 10 (2.3) |  |  |
 TDF + 3TC (or FTC) + DTG |  |  | 344 (78.4) |  |  |
 AZT + 3TC + NVP (or EFV) |  |  | 1 (0.23) |  |  |
 ABC + 3TC + EFV |  |  | 5 (1.1) |  |  |
 AZT + 3TC + LPV/r |  |  | 15 (3.4) |  |  |
 AZT + 3TC + ATV/r |  |  | 11 (2.5) |  |  |
 TDF + 3TC + ATV/r |  |  | 29 (6.6) |  |  |
 TDF + 3TC + LPV/r |  |  | 24 (5.5) |  |  |
Regimen Line, n (%) | 439 | Â | Â | Â | Â |
 1st Line |  |  | 360 (82.0) |  |  |
 2nd Line |  |  | 79 (18.0) |  |  |
Log10 Plasma HIV RNA copies/ml, Mean (SD) | 430 | Â | 1.3 (1.3, 1.5) | Â | Â |
Viral Load Category, n (%) | 430 | Â | Â | Â | Â |
  < 20 |  |  | 291 (67.7) |  |  |
 20–49 |  |  | 60 (13.9) |  |  |
 50–99 |  |  | 19 (4.4) |  |  |
 100–199 |  |  | 14 (3.3) |  |  |
 200–399 |  |  | 9 (2.1) |  |  |
 400–999 |  |  | 4 (0.9) |  |  |
  >  = 1000 |  |  | 33 (7.7) |  |  |